Cargando…

Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells

BACKGROUND: Human induced pluripotent stem cells (hiPSCs) represent a potentially unlimited source of pancreatic endocrine lineage cells. Although insulin-producing β cells derived from hiPSCs have been successfully induced, much work remains to be done to achieve mature β cells. Lysine-specific dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiao-Fei, Zhou, Shu-Yan, Wang, Ce, Huang, Wei, Li, Ning, He, Fei, Li, Fu-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238565/
https://www.ncbi.nlm.nih.gov/pubmed/32430053
http://dx.doi.org/10.1186/s13287-020-01694-8
_version_ 1783536556862078976
author Yang, Xiao-Fei
Zhou, Shu-Yan
Wang, Ce
Huang, Wei
Li, Ning
He, Fei
Li, Fu-Rong
author_facet Yang, Xiao-Fei
Zhou, Shu-Yan
Wang, Ce
Huang, Wei
Li, Ning
He, Fei
Li, Fu-Rong
author_sort Yang, Xiao-Fei
collection PubMed
description BACKGROUND: Human induced pluripotent stem cells (hiPSCs) represent a potentially unlimited source of pancreatic endocrine lineage cells. Although insulin-producing β cells derived from hiPSCs have been successfully induced, much work remains to be done to achieve mature β cells. Lysine-specific demethylase 1 (LSD1) plays an important role in the regulation of hiPSC self-renewal and differentiation. We propose a new strategy to acquire insulin-producing cells (IPCs) from hiPSCs by knocking down LSD1. METHODS: Knockdown of LSD1 in hiPSCs with five shRNA. Assessment of the effects of shRNA on hiPSC proliferation, cell cycle, and apoptosis. Using knockdown hiPSCs with 31.33% LSD1 activity, we achieved a four-step differentiation into IPCs and test its differentiation efficiency, morphology, and marker genes and proteins. We implanted the IPCs into the renal subcapsular of SCID-Beige diabetic mice to evaluate the hypoglycemic effect in vivo. We tested LSD1 and HDAC1 whether they are present in the CoREST complex through IP-WB, and analyzed LSD1, CoREST, HDAC1, H3K4me2/me3, and H3K27me3 protein expression before and after knockdown of LSD1. RESULTS: Differentiated hiPSCs were 38.32% ± 3.54% insulin-positive cells and released insulin/C-peptide in response to glucose stimulus in a manner comparable to adult human islets. Most of the IPCs co-expressed mature β cell-specific markers. When transplanted under the left renal capsule of SCID-Beige diabetic mice, these IPCs reversed hyperglycemia, leading to a significant increase in the definitive endoderm cells. IP-WB results showed that LSD1, HDAC1, and CoREST formed a complex in hiPSCs. Chip-PCR results showed that LSD1, HDAC1, and CoREST were enriched in the same district during the SOX17 and FOXA2 promoter region. Inhibition of LSD1 would not affect the level of CoREST but decreased the HDAC1 expressions. The H3K4me2/me3 and H3K9act level of SOX17 and FOXA2 promoter region increased after inhibited of LSD1, and promoted transcriptional activation. The H3K4me2/me3 and H3K9act level of OCT4 and SOX2 promoter region decreased with the transcriptional repressed. CONCLUSIONS: LSD1 regulated histone methylation and acetylation in promoter regions of pluripotent or endodermal genes. Our results suggest a highly efficient approach to producing IPCs from hiPSCs.
format Online
Article
Text
id pubmed-7238565
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72385652020-05-27 Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells Yang, Xiao-Fei Zhou, Shu-Yan Wang, Ce Huang, Wei Li, Ning He, Fei Li, Fu-Rong Stem Cell Res Ther Research BACKGROUND: Human induced pluripotent stem cells (hiPSCs) represent a potentially unlimited source of pancreatic endocrine lineage cells. Although insulin-producing β cells derived from hiPSCs have been successfully induced, much work remains to be done to achieve mature β cells. Lysine-specific demethylase 1 (LSD1) plays an important role in the regulation of hiPSC self-renewal and differentiation. We propose a new strategy to acquire insulin-producing cells (IPCs) from hiPSCs by knocking down LSD1. METHODS: Knockdown of LSD1 in hiPSCs with five shRNA. Assessment of the effects of shRNA on hiPSC proliferation, cell cycle, and apoptosis. Using knockdown hiPSCs with 31.33% LSD1 activity, we achieved a four-step differentiation into IPCs and test its differentiation efficiency, morphology, and marker genes and proteins. We implanted the IPCs into the renal subcapsular of SCID-Beige diabetic mice to evaluate the hypoglycemic effect in vivo. We tested LSD1 and HDAC1 whether they are present in the CoREST complex through IP-WB, and analyzed LSD1, CoREST, HDAC1, H3K4me2/me3, and H3K27me3 protein expression before and after knockdown of LSD1. RESULTS: Differentiated hiPSCs were 38.32% ± 3.54% insulin-positive cells and released insulin/C-peptide in response to glucose stimulus in a manner comparable to adult human islets. Most of the IPCs co-expressed mature β cell-specific markers. When transplanted under the left renal capsule of SCID-Beige diabetic mice, these IPCs reversed hyperglycemia, leading to a significant increase in the definitive endoderm cells. IP-WB results showed that LSD1, HDAC1, and CoREST formed a complex in hiPSCs. Chip-PCR results showed that LSD1, HDAC1, and CoREST were enriched in the same district during the SOX17 and FOXA2 promoter region. Inhibition of LSD1 would not affect the level of CoREST but decreased the HDAC1 expressions. The H3K4me2/me3 and H3K9act level of SOX17 and FOXA2 promoter region increased after inhibited of LSD1, and promoted transcriptional activation. The H3K4me2/me3 and H3K9act level of OCT4 and SOX2 promoter region decreased with the transcriptional repressed. CONCLUSIONS: LSD1 regulated histone methylation and acetylation in promoter regions of pluripotent or endodermal genes. Our results suggest a highly efficient approach to producing IPCs from hiPSCs. BioMed Central 2020-05-19 /pmc/articles/PMC7238565/ /pubmed/32430053 http://dx.doi.org/10.1186/s13287-020-01694-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Xiao-Fei
Zhou, Shu-Yan
Wang, Ce
Huang, Wei
Li, Ning
He, Fei
Li, Fu-Rong
Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title_full Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title_fullStr Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title_full_unstemmed Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title_short Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
title_sort inhibition of lsd1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238565/
https://www.ncbi.nlm.nih.gov/pubmed/32430053
http://dx.doi.org/10.1186/s13287-020-01694-8
work_keys_str_mv AT yangxiaofei inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT zhoushuyan inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT wangce inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT huangwei inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT lining inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT hefei inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells
AT lifurong inhibitionoflsd1promotesthedifferentiationofhumaninducedpluripotentstemcellsintoinsulinproducingcells